Purchases and Sales Made in Q1 2023 in Eiger Bio Pharmaceuticals, Inc. (EIGR)
This table provides information about the institutional ownership of Eiger Bio Pharmaceuticals, Inc. (EIGR) during Q1 2023. The information is specifically focused on institutions that hold shares of Eiger BioPharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-55.4K- 38.41% |
$49.3K - $140K
|
88.9K
$154K
|
|
|
May 12, 2023
Q1 2023
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-85.1K- 29.5% |
$75.7K - $214K
|
203K
$352K
|
|
|
May 12, 2023
Q1 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-202K- 33.25% |
$179K - $508K
|
405K
$700K
|
|
|
May 11, 2023
Q1 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-208K- 42.41% |
$185K - $524K
|
282K
$489K
|
|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-222K- 77.11% |
$198K - $560K
|
66K
$114K
|
|
|
May 15, 2023
Q1 2023
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-290K- 59.68% |
$258K - $730K
|
196K
$339K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-753K- 98.2% |
$670K - $1.9M
|
13.8K
$23.9K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-756K- 91.15% |
$672K - $1.9M
|
73.4K
$127K
|
|
|
May 04, 2023
Q1 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-1.59M- 98.68% |
$1.42M - $4.02M
|
21.3K
$36.8K
|